Clinical trial tracker

Clinical trial tracker

Looking for Lilly’s LY4086940? Its two registered trials, NCT06945419 and NCT07890376, are listed below. For what they test and what has not been disclosed, see the LY4086940 profile or our LY4086940 write-up.

Reset

2 registered trials, newest registry update first. Showing only trials linked to Nisotirostide.

TrialCompoundPhaseStatusSponsorEnrolledPrimary completionRegistry updated
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
NCT06897475
NisotirostidePhase 2RecruitingEli Lilly and Company200May 2027Nov 4, 2026
A Study of LY3457263 in Obese Participants
NCT05582096
NisotirostidePhase 1CompletedEli Lilly and Company38Jun 8, 2023Jul 18, 2023

Data: ClinicalTrials.gov, U.S. National Library of Medicine. Registered trials only. This table does not report results or recommend anything.